Perspective Therapeutics (CATX) Total Non-Current Liabilities (2011 - 2026)

Perspective Therapeutics' Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $62.9 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 41.15% year-over-year to $62.9 million; the TTM figure through Mar 2026 stood at $62.9 million (up 41.15% YoY), while the FY2025 annual figure was $59.6 million, up 18.22% from the prior year.
• Total Non-Current Liabilities came in at $62.9 million for Q1 2026 at Perspective Therapeutics, up from $59.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $62.9 million in Q1 2026 to a low of $2.3 million in Q1 2022.
• A 5-year average of $30.5 million and a median of $33.6 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities soared 713.47% in 2023 and declined 16.57% in 2025, its largest moves.
• Perspective Therapeutics' Total Non-Current Liabilities stood at $2.8 million in 2022, then jumped by 713.47% to $22.7 million in 2023, then soared by 121.81% to $50.4 million in 2024, then rose by 18.22% to $59.6 million in 2025, then grew by 5.61% to $62.9 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $62.9 million, $59.6 million, and $52.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison